ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Skyrizi 600 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung - 
68947001 AbbVie AG
Skyrizi 600 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung14.09.2023
  14.09.2023
Risankizumab (L04AC18) 
WHO-DDD13.09.2028
07.15. 
07.15. 
B  
Yes 
IP 
2297.30Yes
    
10 %2514.85
7680689470016Biotechnologika
  
Composition
risankizumabum 600 mg, natrii acetas trihydricus corresp. natrium 2.09 mg, acidum aceticum glaciale, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 10 ml.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Risankizumabum600mg / 10ml
BAG: Active AgentDose
Risankizumabum600 mg
 
Inactive agents
Acidum Aceticum Glaciale
Sodium Acetate Trihydrate
Polysorbatum 20
Trehalosum Dihydricum
 
Source
Data was imported : 12.03.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home